Episode description
57: Crafting a Solid CMC Strategy: Key Factors and Common Pitfalls w/ Matthias Müllner - Part 1
Episode description
Join us for an insightful episode as we dive into the world of bioprocess CMC development strategies with Matthias Müllner, CEO of & Co-Founder bespark*bio, a company empowering viral vector-based medicines.
Matthias shares his wealth of knowledge on avoiding common pitfalls in developing robust Chemistry, Manufacturing, and Controls (CMC) strategies. He also emphasizes the critical elements that ensure your biotech product's success.
Key Takeaways:
- Start Strong: Establishing a comprehensive CMC plan early can prevent costly and time-consuming issues later.
- Leverage Expertise: Bringing in external CMC consultants early on can bridge knowledge gaps and streamline the development process.
- Build Internally: Gradually develop in-house CMC capabilities to enhance long-term project viability and attract investor confidence.
Tune in to learn how a solid CMC strategy can be the cornerstone of your biotech product's success and ensure you avoid common mistakes that could derail your project.
Connect with Matthias Müllner:
LinkedIn: https://www.linkedin.com/in/matthias-muellner
Next Step:
Enhance your bioprocess development strategy! Schedule your free assessment to propel your success: https://bruehlmann-consulting.com/assessment